US Patent Issued to Elevaid Therapeutics on March 11 for "Use of atovaquone and proguanil for treatment of gastrointestinal diseases and inflammation" (Arizona Inventor)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,245,994, issued on March 11, was assigned to Elevaid Therapeutics Inc. (Chandler, Ariz.).

"Use of atovaquone and proguanil for treatment of gastrointestinal diseases and inflammation" was invented by Joseph David (Chandler, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to the use of atovaquone or a salt thereof, and, optionally, proguanil or a salt thereof, for the treatment of various human diseases and conditions, including gastrointestinal disorders and, in particular, those associated with inflammation, such as inflammatory bowel disease (IBD), ulcerative colitis (UC), and Crohn's disease (CD)."

The patent was filed o...